China Biotech Deal Volume Surged 81% as Western Pharma Doubles Down
A BIO China panel based on anonymous survey data from BD heads and senior dealmakers revealed that nearly 80%...
Chinese Biotechs Shift From Building to Partnering as Deal Values Double
At BIO China, pharma executives and investors debated whether Chinese biotechs should pursue full integration or adopt partnership-led growth...
China Biotech Dealmaking Shifts from Opportunistic to Strategic
At BIO-Europe Spring 2026, industry leaders from AstraZeneca, Kelun-Biotech, Harbour BioMed, and Panacea Capital dissected the structural forces driving...
AI Rewires Biopharma BD — From Data Grunt to Strategic Lever
At BIO-Europe Spring 2026, a cross-sector panel dissected how generative AI is restructuring the business development workflow — from...
Europe’s Biotech Execution Gap Demands Capital Reform and Regulatory Harmony
At BIO-Europe Spring 2026 in Lisbon, investors and pharma executives diagnosed Europe's biotech bottleneck not as a science deficit...
AI Rewires Drug Discovery’s Economics, Infrastructure, and Biology Itself
At BIO-Europe Spring 2026, leaders from Eli Lilly, Schrödinger, Boltz, Bioptimus, and Sofinnova Partners convened to diagnose how foundation...
Global Biopharma Anchors Deals Amidst Macroeconomic Shifts and Neuroscience Renaissance
At the BIO-Europe Spring 2026 conference in Lisbon, a distinguished panel of business development and finance leaders convened to...
Navigating the 2026 Biotech Macro Environment and Strategic Execution
At the 2026 SCOPE Summit, Scott Megaffin, CEO of Adiso Therapeutics, detailed a transition from the economic ebb of...
Capital Markets and European Biotech: Navigating the Multi-Billion Dollar Innovation Cycle
The global life sciences sector is currently navigating a significant transition in capital market dynamics, shifting from a period...
Abivax Strategic Turnaround: From Near Bankruptcy to Record-Breaking Biotech Funding
At a featured session during the 2025 BIO-Europe conference, leaders from Abivax and Sofinnova Partners detailed the dramatic transformation...